Eric A. Espiner

16.2k total citations · 1 hit paper
343 papers, 12.9k citations indexed

About

Eric A. Espiner is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric A. Espiner has authored 343 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Cardiology and Cardiovascular Medicine, 109 papers in Endocrinology, Diabetes and Metabolism and 70 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric A. Espiner's work include Heart Failure Treatment and Management (144 papers), Hormonal Regulation and Hypertension (53 papers) and Adrenal Hormones and Disorders (33 papers). Eric A. Espiner is often cited by papers focused on Heart Failure Treatment and Management (144 papers), Hormonal Regulation and Hypertension (53 papers) and Adrenal Hormones and Disorders (33 papers). Eric A. Espiner collaborates with scholars based in New Zealand, United States and Australia. Eric A. Espiner's co-authors include Mark Richards, Timothy G. Yandle, M. Gary Nicholls, Hamid Ikram, R. A. DONALD, M. Gary Nicholls, Ian Crozier, Chris Frampton, Penny J. Hunt and Christopher J. Charles and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Eric A. Espiner

337 papers receiving 12.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin

1998 545 citations Mark Richards, M. Gary Nicholls et al. profile →

Peers

Countries citing papers authored by Eric A. Espiner

Since Specialization

Citations

This map shows the geographic impact of Eric A. Espiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric A. Espiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric A. Espiner more than expected).

Fields of papers citing papers by Eric A. Espiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric A. Espiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric A. Espiner. The network helps show where Eric A. Espiner may publish in the future.

Co-authorship network of co-authors of Eric A. Espiner

This figure shows the co-authorship network connecting the top 25 collaborators of Eric A. Espiner. A scholar is included among the top collaborators of Eric A. Espiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric A. Espiner. Eric A. Espiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolism of Natriuretic peptides and impact on insulin resistance and fat mass in healthy subjects 2025 ·Clinical Biochemistry ·Timothy C. R. Prickett, Lynley K. Lewis, John F. Pearson, Eric A. Espiner	0
2	Haemodynamic, hormonal and renal actions of osteocrin in normal sheep 2024 ·Experimental Physiology ·Nicola Scott, Timothy C. R. Prickett, Christopher J. Charles, Eric A. Espiner, Mark Richards, Miriam T. Rademaker	3
3	Resveratrol‐Induced Suppression of C‐type Natriuretic Peptide Associates With Increased Vertebral Bone Density in Postmenopausal Women 2023 ·JBMR Plus ·Timothy C. R. Prickett, Peter R.C. Howe, Eric A. Espiner	5
4	Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities 2018 ·The American Journal of Human Genetics ·Eveline Boudin, (unknown), Timothy C. R. Prickett, Bruno Lapauw, Kaatje Toye, Viviane Van Hoof, Ilse Luyckx, Aline Verstraeten, H. S. A. Heymans, (unknown), Lut Van Laer, Ian Berry, Angus Dobbie, Ed Blair, Bart Loeys, Eric A. Espiner, Jan M. Wit, Wim Van Hul, Peter Houpt, Geert Mortier	25
5	Sustained increases in plasma C-type natriuretic peptides fail to increase concentrations in cerebrospinal fluid: Evidence from pregnant sheep 2015 ·Peptides ·(unknown), Graham K. Barrell, Timothy C. R. Prickett, Eric A. Espiner	7
6	The trophoblast binucleate cell is the source of maternal circulating C-type natriuretic peptide during ovine pregnancy 2011 ·Placenta ·(unknown), Graham K. Barrell, F. B. P. Wooding, Timothy C. R. Prickett, Eric A. Espiner	8
7	Emerging roles for CNP 2008 ·Eric A. Espiner, Timothy C. R. Prickett, (unknown), Timothy G. Yandle, Christopher W. H. Rumball, Jane E. Harding	1
8	ABCs of Natriuretic Peptides: Growth 2007 ·Hormone Research in Paediatrics ·Eric A. Espiner, Timothy C. R. Prickett, Timothy G. Yandle, Graham K. Barrell, Martin Wellby, Michael Sullivan, Brian A. Darlow	1
9	Exponential increase in clinical use of plasma brain natriuretic peptide (BNP) assays. 2004 ·PubMed ·Timothy G. Yandle, Steve Fisher, John C. Livesey, Eric A. Espiner, Mark Richards, Gary Nicholls	5
10	Antecedent hypertension and heart failure after myocardial infarction 2002 ·Journal of the American College of Cardiology ·Mark Richards, M. Gary Nicholls, Richard W. Troughton, John G. Lainchbury, John F. Elliott, Christopher Frampton, Eric A. Espiner, Ian Crozier, Timothy G. Yandle, John G. Turner	77
11	Infusion or co-infusion of brain natriuretic peptide and/or adrenomedullin in human heart failure 1998 ·Journal of the American College of Cardiology ·(unknown), Mark Richards, M. Gary Nicholls, Eric A. Espiner, (unknown)	2
12	The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. 1996 ·Endocrinology ·Vicky A. Cameron, (unknown), Leigh J. Ellmers, Martin A. Kennedy, Eric A. Espiner	107
13	Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. 1996 ·The Journal of Clinical Endocrinology & Metabolism ·Penny J. Hunt, Eric A. Espiner, M. Gary Nicholls, Mark Richards, Timothy G. Yandle	70
14	Blockade of the renin-angiotensin system. 1994 ·PubMed ·M. Gary Nicholls, Christopher J. Charles, Ian Crozier, Eric A. Espiner, Hamid Ikram, Marius Rademaker, Mark Richards, Timothy G. Yandle	21
15	Atrial natriuretic peptide and water and electrolyte transport in the human jejunum. 1991 ·Gut ·(unknown), (unknown), G.O. Barbezat, Timothy G. Yandle, Eric A. Espiner	4
16	EC 24.11 Inhibition in Man Alters Clearance of Atrial Natriuretic Peptide* 1991 ·The Journal of Clinical Endocrinology & Metabolism ·Mark Richards, Gary Wittert, Eric A. Espiner, Timothy G. Yandle, Chris Frampton, Hamid Ikram	17
17	Effect of stilboestrol on sodium balance, cardiac state, and renin-angiotensin-aldosterone activity in prostatic carcinoma. 1985 ·BMJ ·Bruce Blyth, (unknown), Eric A. Espiner, M. Gary Nicholls, John V. Conaglen, Nigel Gilchrist	6
18	Hyponatraemia in congestive heart failure during treatment with captopril. 1980 ·BMJ ·M. Gary Nicholls, Eric A. Espiner, Hamid Ikram, A H Maslowski	19
19	Measurement of pituitary hormones: clinical applications. 5. Prolactin. 1976 ·PubMed ·R. A. DONALD, Eric A. Espiner, S. Hodgkinson, (unknown)	9
20	NON-SPECIFIC ISLET-CELL TUMOUR OF THE PANCREAS WITH DIARRHOEA 1962 ·QJM ·Eric A. Espiner, D. W. BEAVEN	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact